For AD, the onset of AI-based diagnostic tools has enhanced the specific detection of blood biomarkers that can be directly correlated with CSF concentrations of Aβ and Tau tangles (d’Abramo et al. 2020; Abukuri 2024; Cheng et al. 2024). This evidence concerns the gene MAPT and Alzheimer disease.